Àá½Ã¸¸ ±â´Ù·Á ÁÖ¼¼¿ä. ·ÎµùÁßÀÔ´Ï´Ù.

³ªÀÌ°ü·ÃȲ¹Ýº¯¼º ȯÀÚ¿¡¼­ EQ-5D¿¡ ÀÇÇØ Æò°¡µÈ »îÀÇ Áú¿¡ ´ëÇÑ ¿¬±¸ A Study on Quality of Life Assessed by EQ-5D in Age-Related Macular Degeneration

´ëÇѽðúÇÐȸÁö 2019³â 21±Ç 4È£ p.553 ~ 564
±èÁ¤Èñ, ¾È¿µÁÖ,
¼Ò¼Ó »ó¼¼Á¤º¸
±èÁ¤Èñ ( Kim Jung-Hee ) 
µ¿³²º¸°Ç´ëÇб³ ¾È°æ±¤Çаú

¾È¿µÁÖ ( An Young-Ju ) 
¹é¼®¹®È­´ëÇб³ ¾È°æ±¤Çаú

Abstract

¸ñÀû : EuroQoL (EQ-5D)¸¦ ÀÌ¿ëÇÏ¿© ³ªÀÌ°ü·ÃȲ¹Ýº¯¼º (age-related macular degeneration, AMD) ȯÀÚµéÀÇ »îÀÇ ÁúÀ» Æò°¡ÇÏ°íÀÚ ÇÏ¿´´Ù.

¹æ¹ý : 2008~2012³âµµ ±¹¹Î°Ç°­¿µ¾çÁ¶»ç ÀڷḦ ÀÌ¿ëÇÏ¿´À¸¸ç, ¾È°ú °ËÁøÀ» ¹ÞÀº 40¼¼ ÀÌ»ó ÃÑ 18007¸íÀ» ´ë»óÀ¸·Î ÇÏ¿´´Ù. ³ªÀÌ°ü·ÃȲ¹Ýº¯¼ºÀº ¹«»êµ¿ ¾ÈÀúÃÔ¿µÀ» ÅëÇÏ¿© Ãʱâ(early)¿Í Èıâ(late)·Î ºÐ·ùÇÏ¿´´Ù. °Ç°­°ü·Ã »îÀÇÁúÀº ¡®EQ-5D¡¯ ôµµ¸¦ »ç¿ëÇÏ¿© ´Ù¼¸ °¡Áö(¿îµ¿´É·Â, ÀÚ±â°ü¸®, Æò¼ÒÈ°µ¿, ÅëÁõ¡¤ºÒÆí, ºÒ¾È¡¤¿ì¿ï)·Î ÃøÁ¤ÇÏ¿´°í,°øº¯·®À» º¸Á¤ÇÑ ´ÙÁß ·ÎÁö½ºÆ½ ȸ±ÍºÐ¼®À» ½ÃÇàÇÏ¿© ³ªÀÌ°ü·Ã Ȳ¹Ýº¯¼º°ú °Ç°­°ü·Ã »îÀÇ ÁúÀÇ ¿¬°ü¼ºÀ» Æò°¡ÇÏ¿´´Ù.

°á°ú : ³ªÀÌ°ü·Ã Ȳ¹Ýº¯¼º ȯÀÚµéÀÇ Æò±Õ ³ªÀÌ´Â Ãʱâ¿Í ¸»±â¿¡¼­ °¢°¢ 64.98¡¾0.39¼¼¿Í 65.97¡¾1.35¼¼·Î ´ëÁ¶±º(54.31¡¾0.14¼¼)¿¡ ºñÇÏ¿© À¯ÀÇÇÏ°Ô ³ô¾Ò´Ù(p<0.001). Ãʱ⠳ªÀÌ°ü·ÃȲ¹Ýº¯¼ºÀÇ °æ¿ì ¿¬·É, ¼ºº°, °ÅÁÖÁö, ±³À°, Á÷¾÷,Èí¿¬, À½ÁÖ, ¿îµ¿, ºñ¸¸, ´ç´¢, ±×¸®°í °íÇ÷¾ÐÀ» º¸Á¤ÇÑ ÈÄ¿¡µµ ´ëÁ¶±º¿¡ ºñÇØ ºÒ¾È¡¤¿ì¿ïÀ» ´À³¢´Â À§ÇèÀÌ 1.42¹è(95%½Å·Ú±¸°£: 1.051.93)³ô¾ÒÀ¸¸ç, Èı⠳ªÀÌ°ü·ÃȲ¹Ýº¯¼ºÀÇ °æ¿ì ¿¬·É, ¼ºº°, ±³À°, Á÷¾÷, Èí¿¬, ±×¸®°í °íÇ÷¾ÐÀ» º¸Á¤ÇÑÈÄ¿¡µµ ´ëÁ¶±º¿¡ ºñÇØ ÀÚ±â°ü¸®¿¡ ¾î·Á¿òÀ» ´À³¥ À§ÇèÀÌ 3.74¹è(95% ½Å·Ú±¸°£: 1.0214.07)³ô¾Ò´Ù.

°á·Ð : ³ªÀÌ°ü·ÃȲ¹Ýº¯¼ºÀº °Ç°­°ü·Ã »îÀÇ Áú°ú ¿¬°ü¼ºÀÌ ÀÖ¾úÀ¸¸ç, ³ªÀÌ°ü·ÃȲ¹Ýº¯¼ºÀÌ È¯ÀÚµéÀÇ ½Ã·Â»Ó¸¸ ¾Æ´Ï¶ó °Ç°­°ú º¹Áö¿Í °°Àº ´õ ³ÐÀº ¹üÀ§¿¡ ¿µÇâÀ» ¹ÌÄ¥ ¼ö ÀÖÀ¸¹Ç·Î ¾È°úÀû Ä¡·á¿Í ÇÔ²² Á¤½ÅÀûÀÎ ÁöÁö°¡ Áß¿äÇÒ °ÍÀ¸·Î »ý°¢µÈ´Ù.

Purpose : To evaluate the quality of life (QoL) in patients with age-related macular degeneration(AMD) with EuroQoL (EQ-5D).

Methods : The number of subjects was 18,007 people over the age of 40 years who were undergonean eye examination using data on the 20082012National Health and Nutrition Survey. AMD wasclassified into early and late stages using angiography. QoL was measured using five measurements(exercise ability, self-care, usual activities, pain/discomfort, anxiety/depression) using the EQ-5D. Multiple logistic regression analysis was conducted to evaluate the association between AMDand QoL, and also adjusted for possible covariates.

Results : The mean age of AMD patients was significantly higher than the control group(54.31¡¾0.14 years) in the early(64.98¡¾0.39 years)and late(65.97¡¾1.35 years) stages. Even afteradjusting for age, gender, residential area, education, occupation, smoking, drinking, exercise,BMI, diabetes and hypertension, anxiety/depression was increased in early AMD(odds ratio=1.42,95% confidence interval=1.051.93).
And even after adjusting for age, gender , education, occupation,smoking and hypertension, the risk of self-care was increased in late AMD(odds ratio=3.74,95% confidence interval=1.0214.07).

Conclusion : AMD was associated with QoL. This associated AMD may affect the wider rangeof patients' visual acuity as well as health and welfare. Therefore mental support with ophthalmictreatment would be considered importantly.

Å°¿öµå

³ªÀÌ°ü·ÃȲ¹Ýº¯¼º; ºÒ¾È; ¿ì¿ï; »îÀÇ Áú; ½Ã·ÂÀå¾Ö
Age-related macular degeneration; Anxiety; Depression; Quality of life; Visual impairment

¿ø¹® ¹× ¸µÅ©¾Æ¿ô Á¤º¸

µîÀçÀú³Î Á¤º¸

KCI